- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01770314
Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication.
Medication Safety Pilot Study
Study Overview
Detailed Description
The goal of the study is to test the efficacy of the pain medication safety intervention for increasing safe management of prescription medication opioids. The study will use a randomized, controlled design that compares the intervention (painACTION medication safety lessons) to a waitlist control condition.
The hypotheses related to efficacy are that, as compared to the control group, people in the experimental group will demonstrate:
- Increased self-efficacy for how to safely manage medications (primary outcome)
- Increased behaviors associated with safely managing medication (secondary outcome)
Participants:
Investigators will recruit the first 148 respondents who meet the inclusion criteria and consent to be in the study.
Experimental Group. Participants will be given instructions via email to review eleven online lessons about opioid medication safety. Instructions will suggest that participants view one lesson per day for eleven consecutive days. Each educational lesson focuses on one or two aspects of medication safety, including how to safely store medication, and the importance of taking medication exactly as prescribed.
Control Group. The control group is a waitlist control. Participants will be given access to painACTION after the intervention period and follow up assessments are completed.
Randomization: Participants will be randomized by gender and age.
Procedure: Participants will be recruited with the help of the participating clinic. Staff members will let people know about the study by giving out informational fliers. The flier will direct people who are interested in participating in the study to an online screener. Those who screen in will automatically be lead to a consent form. Participants randomized to use painACTION will be sent the link to the online program and provided with a code that will serve as a Personal Identification Number (PIN) to access the program and return for subsequent sessions. The codes will also allow research staff to track program activity. The numbers are generated as participants agree to participate in the study and will begin with 0001 and continue to 0140 as the investigators add participants. The Research Coordinator will only provide assistance with the technical aspects of navigating the program. All assessments will be administered online. The battery will take no more than thirty minutes to complete. Several studies have determined that online assessments have many advantages over other modes of data collection (Webb et al., 1999; Yun, 2000). Online administration allows: (1) automation of the data collection process; (2) standardization of administration; (3) the use of personalized e-mail invitations at the precise assessment time points; (4) opportunities for participants to complete questionnaires on their own time and in the setting most comfortable to them; and (5) greater protection of confidentiality and conservation of resources because no written record exists. In addition, a number of studies have demonstrated that participants prefer computer-assisted self-interviews to traditional methods of data collection, and are more honest with computers (Johnston & Walton, 1995, Paperny et al., 2000). The increase in precision translates to greater power to detect real effect differences and higher confidence in the validity of the data. Information will not be saved if the browser is closed and the questionnaire has not been completed and submitted.
Assessments: Data will be collected from participants at baseline, immediately after the intervention, and one month post intervention.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Newton, Massachusetts, United States, 02464
- Inflexxion Inc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Be willing and able to provide consent
- Have the ability to read and write English
- Diagnosis of non-cancer chronic pain
- Prescribed opioids and taking consistently for 3 months.
- Over 18 years old
Exclusion Criteria:
- Previously visited painACTION
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
Participants will be given instructions via email to review eleven online lessons about opioid medication safety.
Instructions will suggest that participants view one lesson per day for eleven consecutive days.
Each educational lesson focuses on one or two aspects of medication safety, including how to safely store medication, and the importance of taking medication exactly as prescribed.
|
Participants will be given instructions via email to review eleven online lessons about opioid medication safety.
Instructions will suggest that participants view one lesson per day for eleven consecutive days.
Each educational lesson focuses on one or two aspects of medication safety, including how to safely store medication, and the importance of taking medication exactly as prescribed.
Other Names:
|
|
No Intervention: Control
The control group is a waitlist control.
Participants will be given access to painACTION after the intervention period and follow up assessments are completed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-efficacy - 8 Item Measure Taps Into Key Concepts Associated With Confidence for Managing Opioid Medications
Time Frame: Baseline - Day 1, Posttest - Day 16 (intervention took 15 days), One month Followup - at 1 month post-intervention
|
Responses are measured on a 4-point Likert scale (1= "Not at all confident" and 4= "Extremely confident"). The total Score range:8=least confident, 32=most confident. How confident do you feel in your ability to do each of the following activities, today?
Internal consistency of the items in the pilot measure will be assessed (Cronbach's alpha). Test-retest reliability will be explored by asking 50 participants in the control group to retake the pilot measure within 3-5 days of having taken the measure as part of the pretest. |
Baseline - Day 1, Posttest - Day 16 (intervention took 15 days), One month Followup - at 1 month post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction With the Program
Time Frame: One-month followup assessment
|
We tested and analyzed participants' satisfaction with the program by asking the question: "Overall, how satisfied were you with the lessons."
They answered on a 4 point Likert scale: 1=Not at all satisfied, 2=Somewhat Satisfied, 3=Satisfied, 4 = Very satisfied.
Higher values indicate higher satisfaction.
|
One-month followup assessment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elizabeth Donovan, Ph. D., Inflexxion, Inc.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MedSafetyStudy
- Endo Pharmaceuticals (Other Identifier: Endo Pharmaceuticals)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medication Adherence
-
NYU Langone HealthRobert Wood Johnson Foundation; New York City Health and Hospitals CorporationCompletedMedication Adherence | Medication ErrorsUnited States
-
Universidad Autonoma de Baja CaliforniaCompletedMedication Adherence | Medication ComplianceMexico
-
Vanderbilt University Medical CenterCompletedAdherence, Medication | Nonadherence, MedicationUnited States
-
Universiti Putra MalaysiaCompletedMedication Adherence | Adherence, TreatmentPakistan
-
University Hospital, Basel, SwitzerlandUniversity of BaselCompletedPolymedication-Check With Insight in Patients' Medication Organisation and Comprehension of GenericsMedication Adherence | Medication Therapy ManagementSwitzerland
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; Sir Halley Stewart TrustCompletedMedication Adherence | Medication Compliance | Attitude | CaregiversUnited Kingdom
-
National Healthcare Group, SingaporeCompletedMedication Adherence | Medication Administered in Error
-
Cliniques universitaires Saint-Luc- Université...RecruitingAdherence, MedicationBelgium
-
Swedish Medical CenterNational Institute of Mental Health (NIMH); University of Washington; University...Recruiting
-
Northwell HealthNational Institute on Aging (NIA)CompletedMedication AdherenceUnited States
Clinical Trials on Experimental
-
Polish Mother Memorial Hospital Research InstituteCompletedBottle Feeding | PrematurePoland
-
Finis Terrae UniversityNot yet recruitingPostoperative Pain | Respiratory ComplicationChile
-
University of Illinois at ChicagoRecruiting
-
Riphah International UniversityRecruitingAthletic Performance | Muscle StrengthPakistan
-
Suleyman Demirel UniversityRecruitingOsteoporosis (Senile)Turkey (Türkiye)
-
University of AlcalaRecruitingTo be Approved by the Ethics CommitteeSpain
-
European University Miguel de CervantesHospital Clínico Universitario de ValladolidNot yet recruiting
-
Amasya UniversityCompleted
-
Le Mans UniversiteActive, not recruiting
-
Center for Health Sciences, SerbiaNot yet recruitingCognitive Deficits, Mild